Keep updated
Get in touch
| Type | Company | [sources] | |||
|---|---|---|---|---|---|
| Name | Chemo Group | [sources] | |||
| Incorporation date | not available | [sources] | |||
| Jurisdiction | not available | [sources] | |||
| Country | Spain | [sources] | |||
| Registration number | not available | [sources] | |||
| Sector | Pharmaceuticals | [sources] | |||
| Website | www.chemogroup.com | [sources] | |||
| Source link | www.unitedagainstnucleariran.com | [sources] | |||
| Last change | Last processed | First seen | |||
"Iranian media reported in March 2016 that Barakat Pharmed had signed a $15 million deal for Spain-based pharmaceutical company Chemo Group to buy a 65 percent stake in a Barakat subsidiary. A 2016 Barakat annual report states that 65 percent of shares of Ati Pharmed, previously owned by Barakat and Alborz Investment Group, a Barakat subsidiary, were transferred to Chemo. A person familiar with Ati Pharmed affairs confirmed the transfer. Chemo officials did not respond to requests for comment." (Reuters, "Post-Sanctions Deals with Iranian Firms Linked to Khamenei," 1/19/2017). (http://www.dailymail.co.uk/wires/reuters/article-4136746/Post-sanctions-deals-Iranian-firms-linked-Khamenei.html)
For experts: raw data explorer
OpenSanctions is free for non-commercial users. Businesses must acquire a data license to use the dataset.
No relationships to other entities found.